Adenylosuccinate lyase deficiency: Clinical Trials

2 trials for Adenylosuccinate lyase deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Adenylosuccinate lyase deficiency: new trials by email Literature Review of Adenylosuccinate lyase deficiency trials Research Report on Adenylosuccinate lyase deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
AMPD3, OMIM*102772, AMP Deaminase Deficiency, AK1, OMIM *103000, Adenylate Kinase Deficiency
RecruitingNational Human Genome Research Institute (NHGRI)9992023-12-192026-08-19
Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency
Allopurinol - Adenylosuccinate Lyase Deficiency
Phase 2CompletedAssistance Publique - Hôpitaux de Paris82019-10-142026-03-04

Narrower conditions

ADA2 protein, human (1)  ·  Adenine phosphoribosyltransferase deficiency (1)  ·  Adenosine monophosphate deaminase deficiency (1)  ·  Anemia (1)  ·  Arts syndrome (1)  ·  Autistic Disorder (1)  ·  Beta-Ureidopropionase Deficiency (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Dihydropyrimidinase Deficiency (1)  ·  Dihydropyrimidine Dehydrogenase Deficiency (1)  ·  Epilepsy (1)  ·  Genee-Wiedemann syndrome (1)  ·  Hemolysis (1)  ·  Hyper-IgM Immunodeficiency Syndrome (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)  ·  Autism Spectrum Disorder (1)  ·  Blood Protein Disorders (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Cardiovascular Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Child Development Disorders, Pervasive (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Dysgammaglobulinemia (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)

Interventions

Allopurinol (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  National Human Genome Research Institute (NHGRI) (1)

Countries

France (1)  ·  United States (1)

Top investigators

Oleg A Shchelochkov, M.D. (1)

Results publications

PMID 41053929

NIH funding

2017 (1)